Friday, 16 October 2026European Markets

GALP ENERGIA-NOM And TECHNIP ENERGIES Have A High Dividend Yield And Return On Equity In The Energy Sector.

Loading stream...

(vianews) - galp energia-nom (galp.ls) is among this list of stock assets with the highest dividend rate and return on equity on the energy sector.

financial asset price forward dividend yield return on equity
galp energia-nom (galp.ls) €13.40 4.3% 31.53%
technip energies (te.pa) €21.13 2.21% 20.6%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. galp energia-nom (galp.ls)

4.3% forward dividend yield and 31.53% return on equity

galp energia, sgps, s.a. operates as an integrated energy operator in portugal and internationally. the company operates through four segments: upstream, industrial & midstream, commercial, and renewables and new business. the upstream segment engages in the exploration, development, and production of hydrocarbons primarily in brazil, mozambique, and angola. the industrial & midstream segment owns refineries in portugal, as well as is involved in activities related to energy management of oil products, gas, and electricity. this segment also provides storage and transportation infrastructure for oil and gas products, as well as engages in the sale of electricity to the grid in portugal and spain. the commercial segment is involved in the areas of retail to final business-to-business and business to consumer customers of oil, gas, and electricity. the renewables and new business segment is involved in the development of solar and wind power generation projects in portugal and spain. in addition, it produces biodiesel, biofuel, and green hydrogen; and operates service stations. further, the company engages in the reinsurance business. the company was formerly known as galp – petróleos e gás de portugal, sgps, s.a. and changed its name to galp energia, sgps, s.a. in september 2000. galp energia, sgps, s.a. was incorporated in 1999 and is headquartered in lisbon, portugal.

earnings per share

as for profitability, galp energia-nom has a trailing twelve months eps of €2.18.

pe ratio

galp energia-nom has a trailing twelve months price to earnings ratio of 6.15. meaning, the purchaser of the share is investing €6.15 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.53%.

moving average

galp energia-nom's value is way above its 50-day moving average of €11.31 and way above its 200-day moving average of €11.40.

growth estimates quarters

the company's growth estimates for the current quarter and the next is 54.5% and 3%, respectively.

yearly top and bottom value

galp energia-nom's stock is valued at €13.40 at 12:30 est, higher than its 52-week high of €13.10.

more news about galp energia-nom.

2. technip energies (te.pa)

2.21% forward dividend yield and 20.6% return on equity

technip energies n.v., together with its subsidiaries, operates as an engineering and technology company for the energy transition in europe, russia, the asia pacific, africa, the middle east, and the americas. the company operates in two segments, projects delivery; and technology, and products and services. it is involved in the engineering, procurement, construction management, commissioning, and transport and installation of various energy projects. the company also engages in the study, engineering, procurement, construction, and project management of various onshore and offshore facilities related to gas monetization, ethylene, hydrogen, refining, and chemical processing from biofuels and hydrocarbons. in addition, it develops, designs, commercializes, and integrates a range of technologies in gas monetization, refining, petrochemicals and fertilizers, hydrogen, and sustainable chemistry; provides land and marine-based loading and transfer systems services to the oil and gas, petrochemical, chemical, and decarbonization industries; and offers a range of project management consulting services to the energy industry. further, the company offers robotics, visual intelligence, and surveillance solutions, as well as nondestructive testing equipment; snaplng, a modularized and electrified solution; proprietary technologies relating to the design and construction of ethylene steam crackers, power generation furnace, and heat transfer equipment; engineering and technical services; and digital services. technip energies n.v. was incorporated in 2019 and is headquartered in nanterre, france.

earnings per share

as for profitability, technip energies has a trailing twelve months eps of €1.72.

pe ratio

technip energies has a trailing twelve months price to earnings ratio of 12.28. meaning, the purchaser of the share is investing €12.28 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.6%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, technip energies's stock is considered to be overbought (>=80).

more news about technip energies.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com